Navigation Links
Genetics may explain high-functioning senior athletes with hip abnormalities

NEW ORLEANS─Genetics may explain why some senior athletes are high functioning despite having one or both hip abnormalities typically associated with early onset osteoarthritis (OA): developmental dislocation of the hip (dysplasia), a loose hip joint; or femoroacetabular impingement (FAI), a condition in which the hip bones are abnormally shaped, according to new research presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

In the study, "Prevalence of Radiographic Abnormalities in Senior Athletes with Well-functioning Hips," researchers evaluated the hips of 546 senior athletes (1,087 hips) with an average age of 67 (57 percent were male) for radiographic signs of FAI and dysplasia. Eighty-two percent of hips had radiographic evidence of FAI; 67 percent had at least one sign of cam FAI, in which the alpha angle of the bone was ≥50 on either hip; and 8 percent had isolated pincer impingement FAI, in which an extra bone extends out over the normal rim of the hip socket. Twenty-four percent of the senior athletes had signs of both cam and pincer FAI. Osteoarthritis was present in 17 percent of the hips. Ninety-three percent of the hips with OA had evidence of FAI, and 10 percent, dysplasia.

While hips with FAI were more likely to have OA, 72 percent of the hips with FAI showed little to no evidence of OA. According to the study authors, the findings may indicate that other factors, possibly genetics or the patient's type of cartilage, may play a role in preserving the hip joints in these high functioning senior athletes.


Contact: Kristina Goel
American Academy of Orthopaedic Surgeons

Page: 1

Related medicine news :

1. Penn study reveals genetics impact risk of early menopause among some female smokers
2. New project on psychiatric, neurologic, and behavioral genetics
3. The epigenetics of breast cancer family history
4. Wake Forest Baptist researchers study alcohol addiction using optogenetics
5. NPC and Beyond Genetics Supplements Announce Hosts for SHREDZ 2013 Tri-State Bodybuilding and Physique Championships
6. EpicGenetics, Inc., Developer of the First Blood Test for Fibromyalgia, Releases Fibromyalgia App
7. Genetics of cervical cancer raise concern about antiviral therapy in some cases
8. Yale researchers unravel genetics of dyslexia and language impairment
9. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
10. Optogenetics is proving to be highly promising in the treatment of obsessive-compulsive disorders
11. XRMD: Beyond AREDS2: Vision Improvement using Hormones, Genetics, Methylation, Nutrition and Anti-Oxidative Therapy
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: